Position in BIIB
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$893,840
+$25,406 QoQ
Shares Held
4,137
-12.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#470
of 1,036 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SUMMITRY LLC holds $46,849,010 across 11 Drug Manufacturers - General names. BIIB ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
75,057 | $27,179,640 | |
| 2 | JNJ |
Johnson & Johnson
|
51,089 | $12,975,073 | |
| 3 | LLY |
ELI LILLY & Co
|
1,711 | $2,052,224 | |
| 4 | ABBV |
AbbVie Inc.
|
4,563 | $1,148,233 | |
| 5 | BIIB |
Biogen Inc.
This page
|
4,137 | $893,840 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,279 | $806,851 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,531 | $491,556 | |
| 8 | NVS |
Novartis AG
|
2,464 | $386,158 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $893,840 | 4,137 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $868,434 | 4,737 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $843,696 | 4,794 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $846,503 | 6,043 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $332,939 | 2,651 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||